Literature DB >> 26614863

Management of Colorectal Cancer in Older Adults.

Joleen M Hubbard1.   

Abstract

Treatment for colorectal cancer should not be based on age alone. Pooled analyses from clinical trials show that fit older adults are able to tolerate treatment well with similar efficacy as younger adults. When an older adult is considered for treatment, the clinical encounter must evaluate for deficits in physical and cognitive function, and assess comorbidities, medications, and the degree of social support, all which have may affect tolerance of treatment. Based on the degree of fitness of the patient, multiple alternatives to aggressive treatment regimens and strategies exist to minimize toxicity and preserve quality of life during treatment.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colon cancer treatment; Geriatric oncology; Rectal cancer treatment

Mesh:

Year:  2015        PMID: 26614863     DOI: 10.1016/j.cger.2015.08.002

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  4 in total

1.  ZEB2 promotes tumor metastasis and correlates with poor prognosis of human colorectal cancer.

Authors:  Ming-Zhe Li; Jing-Jing Wang; Shi-Bin Yang; Wen-Feng Li; Long-Bin Xiao; Yu-Long He; Xin-Ming Song
Journal:  Am J Transl Res       Date:  2017-06-15       Impact factor: 4.060

2.  Histopathological and biochemical assessment of liver damage in albino Wistar rats treated with cytotoxic platinum compounds in combination with 5-fluorouracil.

Authors:  Nusrat Bano; Rahila Najam
Journal:  Arch Med Sci       Date:  2019-06-20       Impact factor: 3.318

3.  CBX8 and CD96 Are Important Prognostic Biomarkers of Colorectal Cancer.

Authors:  Xin Song; Tao Tang; Chaofeng Li; Xin Liu; Lei Zhou
Journal:  Med Sci Monit       Date:  2018-11-01

4.  CD31 and D2-40 Contribute to Peritoneal Metastasis of Colorectal Cancer by Promoting Epithelial-Mesenchymal Transition.

Authors:  Xinqiang Zhu; Gang Zhou; Peng Ni; Xuetong Jiang; Hailong Huang; Jianqiang Wu; Xiaohong Shi; Xiaoling Jiang; Jianing Liu
Journal:  Gut Liver       Date:  2021-03-15       Impact factor: 4.519

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.